
IndraLab
Statements
Calcitriol inhibits KCNH1. 1 / 1
|
1
sparser
"Therefore, the rationale of the combined therapy proposed herein is based on Eag1 gene expression inhibition by calcitriol, together with the functional blockade of K + currents through this particular channel by astemizole, in order to potentiate the antineoplastic effects of both compounds."